Mrs Courtney Dean Borruso, DO | |
2131 Lake Ave Suite 4, Ashtabula, OH 44004 | |
(440) 964-3733 | |
(440) 964-7069 |
Full Name | Mrs Courtney Dean Borruso |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 2131 Lake Ave Suite 4, Ashtabula, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295990158 | NPI | - | NPPES |
1024998940003 | Medicaid | PA | |
002518014 | Other | PA | HIGHMARK BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | OS015061 (Pennsylvania) | Secondary |
207R00000X | Internal Medicine | 34.011500 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Courtney Dean Borruso, DO 2131 Lake Ave. Suite 4, Ashtabula, OH 44004 Ph: (440) 964-3733 | Mrs Courtney Dean Borruso, DO 2131 Lake Ave Suite 4, Ashtabula, OH 44004 Ph: (440) 964-3733 |
News Archive
A study led by Johns Hopkins Bloomberg School of Public Health researchers that tracked activity levels of 646 adults over 30 years found that, contrary to previous research, exercise in mid-life was not linked to cognitive fitness in later years.
The organic food industry has grown from fresh produce and grains to snack foods and condiments-from farmers markets to supercenters. Has this new variety in organic products, and the availability of them, affected consumers' perceptions? A University of Illinois researcher and her team designed an experiment to provide insight on some of the variables that may influence opinions about organic foods.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, at the 2007 annual meeting of the American Psychiatric Association.
Adults with attention-deficit/hyperactivity disorder (ADHD) who received medication and individual sessions of cognitive behavioral therapy (CBT) showed greater improvement in symptoms through 12 months compared to patients who did not receive CBT, according to a study in the August 25 issue of JAMA.
› Verified 4 days ago
Arthur W Molinoff, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2121 Lake Avenue, Ashtabula, OH 44004 Phone: 440-998-4775 Fax: 440-998-5922 | |
Dr. Mohammad Ali Varghai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2420 Lake Ave, Ashtabula, OH 44004 Phone: 440-994-7600 Fax: 440-994-7603 | |
Dr. Kelvin Arlson Cenac, MBBS Internal Medicine Medicare: Medicare Enrolled Practice Location: 2420 Lake Ave, Ashtabula, OH 44004 Phone: 409-972-2624 | |
Edward A Wiese, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2422 Lake Ave, Ashtabula, OH 44004 Phone: 440-992-4422 | |
Dr. Orlando Antonio Dsilva, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Lake Ave, Ashtabula, OH 44004 Phone: 440-964-7121 Fax: 440-964-2251 | |
Dr. Harithsa Srinath Asuri, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2210 S Ridge Rd E, Ashtabula, OH 44004 Phone: 513-834-7063 Fax: 513-873-1567 |